216 related articles for article (PubMed ID: 29769263)
1. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa.
Gopal S; Gross TG
Blood; 2018 Jul; 132(3):254-263. PubMed ID: 29769263
[TBL] [Abstract][Full Text] [Related]
2. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa.
Ozuah NW; Lubega J; Allen CE; El-Mallawany NK
Blood Adv; 2020 Aug; 4(16):4007-4019. PubMed ID: 32841337
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S
Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study.
Silva WFD; Garibaldi PMM; Rosa LID; Bellesso M; Clé DV; Delamain MT; Rego EM; Pereira J; Rocha V
Leuk Res; 2020 Feb; 89():106287. PubMed ID: 31864677
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi.
Stanley CC; Westmoreland KD; Heimlich BJ; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kaimila B; Kasonkanji E; Chimzimu F; Kampani C; Dhungel BM; Krysiak R; Montgomery ND; Fedoriw Y; Rosenberg NE; Liomba NG; Gopal S
Br J Haematol; 2016 Jun; 173(5):705-12. PubMed ID: 26914979
[TBL] [Abstract][Full Text] [Related]
6. Challenge of pediatric oncology in Africa.
Hadley LG; Rouma BS; Saad-Eldin Y
Semin Pediatr Surg; 2012 May; 21(2):136-41. PubMed ID: 22475119
[TBL] [Abstract][Full Text] [Related]
7. Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique.
Bouda GC; Traoré F; Couitchere L; Raquin MA; Guedenon KM; Pondy A; Moreira C; Rakotomahefa M; Harif M; Patte C
J Glob Oncol; 2019 Nov; 5():1-9. PubMed ID: 31794283
[TBL] [Abstract][Full Text] [Related]
8. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.
Egan G; Goldman S; Alexander S
Br J Haematol; 2019 Jun; 185(6):1071-1085. PubMed ID: 30613948
[TBL] [Abstract][Full Text] [Related]
9. Treating Burkitt Lymphoma in Adults.
Casulo C; Friedberg J
Curr Hematol Malig Rep; 2015 Sep; 10(3):266-71. PubMed ID: 26013028
[TBL] [Abstract][Full Text] [Related]
10. Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?
Naresh KN; Raphael M; Ayers L; Hurwitz N; Calbi V; Rogena E; Sayed S; Sherman O; Ibrahim HA; Lazzi S; Mourmouras V; Rince P; Githanga J; Byakika B; Moshi E; Durosinmi M; Olasode BJ; Oluwasola OA; Akang EE; Akenòva Y; Adde M; Magrath I; Leoncini L
Br J Haematol; 2011 Sep; 154(6):696-703. PubMed ID: 21707579
[TBL] [Abstract][Full Text] [Related]
11. Burkitt lymphoma in adults.
Linch DC
Br J Haematol; 2012 Mar; 156(6):693-703. PubMed ID: 21923642
[TBL] [Abstract][Full Text] [Related]
12. Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries.
Ndounga Diakou LA; Ntoumi F; Ravaud P; Boutron I
J Clin Epidemiol; 2017 Feb; 82():29-36.e6. PubMed ID: 27865901
[TBL] [Abstract][Full Text] [Related]
13. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
14. Paediatric surgical outcomes in sub-Saharan Africa: a multicentre, international, prospective cohort study.
PaedSurg Africa Research Collaboration
BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34475022
[TBL] [Abstract][Full Text] [Related]
15. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma.
Carrillo-Cruz E; Marín-Oyaga VA; Solé Rodríguez M; Borrego-Dorado I; de la Cruz Vicente F; Quiroga Cantero E; Manzanares Pérez M; Capote FJ; Ramírez Sánchez MJ; Espigado Tocino I; Pérez-Vega H; Vázquez-Albertino R; Pérez-Simón JA
Eur J Haematol; 2015 Jan; 94(1):23-30. PubMed ID: 24520874
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa.
Chamba C; Mbulaiteye SM; Balandya E; Schuh A
Camb Prism Precis Med; 2023; 1():e13. PubMed ID: 38550928
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
Miles RR; Arnold S; Cairo MS
Br J Haematol; 2012 Mar; 156(6):730-43. PubMed ID: 22260323
[TBL] [Abstract][Full Text] [Related]
18. Evolution of paediatric oncology over the years: overview with a focus on sub-Saharan Africa and examples from the Kenyan experience.
Kasili EG
East Afr Med J; 1993 Jun; 70(6):343-7. PubMed ID: 8261955
[TBL] [Abstract][Full Text] [Related]
19. Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy.
Woessmann W; Zimmermann M; Meinhardt A; Müller S; Hauch H; Knörr F; Oschlies I; Klapper W; Niggli F; Kabickova E; Attarbaschi A; Reiter A; Burkhardt B
Blood; 2020 Apr; 135(14):1124-1132. PubMed ID: 31961927
[TBL] [Abstract][Full Text] [Related]
20. Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting.
Hesseling P; Israels T; Harif M; Chantada G; Molyneux E;
Pediatr Blood Cancer; 2013 Mar; 60(3):357-62. PubMed ID: 23192950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
